Targeting the Fcμ-Receptor in Chronic Lymphocytic Leukemia With a Novel IgM-derived Antibody-Drug Conjugate
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-1-s1-p136
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2013
Authors
Publisher
BMJ